MAPT and Alzheimer disease: Plasma tau phosphorylated at threonine 181 (P‐tau181), a recognised Alzheimer's disease (AD) biomarker, was reported to reflect early cortical Aβ deposition; however, the biochemical mechanisms associated with initial Aβ pathology remain to be investigated.